FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology firm with a market ...
Piper Sandler's analysts increased the price target for Becton Dickinson (NYSE:BDX) shares to $280 from $275, while ...
Dickinson and Co. or BD (BDX), and health care technology company Babson Diagnostics, announced Tuesday an expansion of fingertip blood collection and testing technologies for use by U.S. health ...
BD (Becton, Dickinson and Company) (NYSE: BDX), and ten23 health, announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology. BD (Becton, Dickinson and ...
After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...
ASCCP and NCI Publish Guidance in the Journal of Lower Genital Tract Disease; BD Onclarity HPV Assay Identifies Risk by HPV Type for Tailored Management CLARKSBURG, MARYLAND / ACCESS Newswire / ...
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.
The company also announced it repurchased $750 million in BD stock to date in fiscal 2025. In addition, the board has authorized the company to repurchase up to 10 million shares of BD common stock in ...
Company will spotlight sustainable solutions to enhance patient safety, workforce well-being, and care delivery efficiency ...
Advancements and Projections in the Global Blood Micro-Sampling Medical Devices Market: Insights, Trends, Opportunities, and ...